{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:47:07Z","timestamp":1791438427956,"version":"4.3.3"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NSF","award":["DGE-1256082"],"award-info":[{"award-number":["DGE-1256082"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI127893"],"award-info":[{"award-number":["R01AI127893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI141707"],"award-info":[{"award-number":["R01AI141707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA039543"],"award-info":[{"award-number":["DA039543"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI120961"],"award-info":[{"award-number":["R01AI120961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.immuni.2018.12.017","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T19:31:42Z","timestamp":1548790302000},"page":"520-532.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes"],"prefix":"10.1016","volume":"50","author":[{"given":"Adam S.","family":"Dingens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Arenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidyn","family":"Weight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Overbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2018.12.017_bib1","doi-asserted-by":"crossref","unstructured":"Adams, R.M., Kinney, J.B., Walczak, A.M., and Mora, T. (2017). Physical epistatic landscape of antibody binding affinity. arXiv, arXiv:1712.04000, https:\/\/arxiv.org\/abs\/1712.04000.","DOI":"10.1101\/232645"},{"key":"10.1016\/j.immuni.2018.12.017_bib2","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1128\/jvi.67.11.6897-6902.1993","article-title":"Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies","volume":"67","author":"Back","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib3","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2018.12.017_bib4","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41591-018-0186-4","article-title":"Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals","volume":"24","author":"Bar-On","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2018.12.017_bib5","doi-asserted-by":"crossref","first-page":"11660","DOI":"10.1038\/ncomms11660","article-title":"Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable","volume":"7","author":"Barton","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2018.12.017_bib6","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1128\/JCM.01481-06","article-title":"Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters","volume":"44","author":"Benki","year":"2006","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.immuni.2018.12.017_bib7","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pmed.0050009","article-title":"Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41","volume":"5","author":"Blish","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.immuni.2018.12.017_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12859-015-0590-4","article-title":"Software for the analysis and visualization of deep mutational scanning data","volume":"16","author":"Bloom","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.immuni.2018.12.017_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/JVI.02680-14","article-title":"Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer","volume":"89","author":"Boyd","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ebiom.2016.08.045","article-title":"Amino Acid Changes in the\u00a0HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity","volume":"12","author":"Bradley","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.immuni.2018.12.017_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10-1074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2018.12.017_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.immuni.2018.12.017_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.virol.2017.02.024","article-title":"Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction","volume":"505","author":"Crooks","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2018.12.017_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1006\/jmbi.1993.1611","article-title":"Comparison of a structural and a functional epitope","volume":"234","author":"Cunningham","year":"1993","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2018.12.017_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1534\/genetics.109.112458","article-title":"Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region","volume":"185","author":"da Silva","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/j.immuni.2018.12.017_bib17","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.1073\/pnas.1105315108","article-title":"Coordinate linkage of HIV evolution reveals regions of immunological vulnerability","volume":"108","author":"Dahirel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.12.017_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.chom.2017.05.003","article-title":"Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody","volume":"21","author":"Dingens","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2018.12.017_bib19","doi-asserted-by":"crossref","first-page":"e1007159","DOI":"10.1371\/journal.ppat.1007159","article-title":"Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV","volume":"14","author":"Dingens","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-018-03665-3","article-title":"How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin","volume":"9","author":"Doud","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2018.12.017_bib21","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JVI.06973-11","article-title":"PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4","volume":"86","author":"Falkowska","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"Falkowska","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2018.12.017_bib23","doi-asserted-by":"crossref","unstructured":"Foley, B., Leitner, T., Apetrei, C., Hahn, B., Mizrachi, I., Mullins, J., Rambaut, A., Wolinsky, S., and Korber, B. (2017). HIV Sequence Compendium 2017.\u00a0Theor. Biol. Biophys. Group, Los Alamos Natl. Lab. NM LA-UR 17-2.\u00a0https:\/\/www.hiv.lanl.gov\/content\/sequence\/HIV\/COMPENDIUM\/2017\/sequence2017.pdf","DOI":"10.2172\/1458915"},{"key":"10.1016\/j.immuni.2018.12.017_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2014.09.009","article-title":"Structural evolution of glycan recognition by a family of potent HIV antibodies","volume":"159","author":"Garces","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2018.12.017_bib25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nsmb.3291","article-title":"Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site","volume":"23","author":"Gristick","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2018.12.017_bib26","doi-asserted-by":"crossref","first-page":"e1006114","DOI":"10.1371\/journal.ppat.1006114","article-title":"Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV\u2019s Envelope Protein on Viral Replication in Cell Culture","volume":"12","author":"Haddox","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib27","doi-asserted-by":"crossref","first-page":"e34420","DOI":"10.7554\/eLife.34420","article-title":"Mapping mutational effects along the evolutionary landscape of HIV envelope","volume":"7","author":"Haddox","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2018.12.017_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib29","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1021\/bi00078a005","article-title":"Thermodynamic analysis of an antibody functional epitope","volume":"32","author":"Kelley","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.immuni.2018.12.017_bib30","doi-asserted-by":"crossref","first-page":"e1004271","DOI":"10.1371\/journal.ppat.1004271","article-title":"Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization","volume":"10","author":"Kim","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib32","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","article-title":"Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody","volume":"352","author":"Kong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","article-title":"HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure","volume":"48","author":"Kwong","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2018.12.017_bib34","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.aad2450","article-title":"Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer","volume":"351","author":"Lee","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.immuni.2017.03.017","article-title":"A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic \u03b2-Hairpin Structure","volume":"46","author":"Lee","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2018.12.017_bib36","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1128\/JVI.00754-11","article-title":"Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01","volume":"85","author":"Li","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib37","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1128\/JVI.01116-16","article-title":"Changes in structure and antigenicity of HIV-1 Env trimers resulting from removal of a conserved CD4 binding site-proximal glycan","volume":"90","author":"Liang","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nsmb.3382","article-title":"Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer","volume":"24","author":"Liu","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2018.12.017_bib39","doi-asserted-by":"crossref","first-page":"E564","DOI":"10.1073\/pnas.1717765115","article-title":"Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies","volume":"115","author":"Louie","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.12.017_bib40","doi-asserted-by":"crossref","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2018.12.017_bib41","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/JVI.03608-14","article-title":"HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies","volume":"89","author":"Lynch","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib42","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1245627","article-title":"Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer","volume":"342","author":"Lyumkis","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/imr.12506","article-title":"HIV antibodies for treatment of HIV infection","volume":"275","author":"Margolis","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2018.12.017_bib44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9","volume":"480","author":"McLellan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with anti-HIV-1 antibodies maintains viral suppression","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib46","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.12.017_bib47","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.1254426","article-title":"Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions","volume":"346","author":"Munro","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib48","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1128\/JVI.01352-12","article-title":"Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies","volume":"86","author":"O\u2019Rourke","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib49","doi-asserted-by":"crossref","first-page":"e1007238","DOI":"10.1371\/journal.ppat.1007238","article-title":"Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies","volume":"14","author":"Otsuka","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/imr.12511","article-title":"Use of broadly neutralizing antibodies for HIV-1 prevention","volume":"275","author":"Pegu","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2018.12.017_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80043-6","article-title":"Neutralizing antibodies have limited effects on the control of established HIV-1 infection in\u00a0vivo","volume":"10","author":"Poignard","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2018.12.017_bib52","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1128\/JVI.73.7.5255-5264.1999","article-title":"Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties","volume":"73","author":"Poss","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib53","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib54","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib56","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib57","doi-asserted-by":"crossref","first-page":"e1003046","DOI":"10.1371\/journal.pcbi.1003046","article-title":"A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein","volume":"9","author":"Sethi","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.immuni.2018.12.017_bib58","doi-asserted-by":"crossref","first-page":"062705","DOI":"10.1103\/PhysRevE.88.062705","article-title":"Spin models inferred from patient-derived viral sequence data faithfully describe HIV fitness landscapes","volume":"88","author":"Shekhar","year":"2013","journal-title":"Phys. Rev. E Stat. Nonlin. Soft Matter Phys."},{"key":"10.1016\/j.immuni.2018.12.017_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"Shingai","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib60","doi-asserted-by":"crossref","first-page":"236ra63","DOI":"10.1126\/scitranslmed.3008104","article-title":"Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV","volume":"6","author":"Sok","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2018.12.017_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2016.06.026","article-title":"A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans","volume":"45","author":"Sok","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2018.12.017_bib62","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2016.04.010","article-title":"Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G","volume":"165","author":"Stewart-Jones","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2018.12.017_bib63","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/JVI.02321-15","article-title":"Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites","volume":"90","author":"Townsley","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib64","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm1244","article-title":"Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies","volume":"11","author":"Trkola","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2018.12.017_bib65","doi-asserted-by":"crossref","first-page":"e1000365","DOI":"10.1371\/journal.ppat.1000365","article-title":"Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response","volume":"5","author":"Troyer","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib66","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1128\/JVI.01351-16","article-title":"Epitope-independent purification of native-like envelope trimers from diverse HIV-1 isolates","volume":"90","author":"Verkerke","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib67","doi-asserted-by":"crossref","first-page":"e1005520","DOI":"10.1371\/journal.ppat.1005520","article-title":"Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection","volume":"12","author":"Wagh","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib68","doi-asserted-by":"crossref","first-page":"e1006860","DOI":"10.1371\/journal.ppat.1006860","article-title":"Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections","volume":"14","author":"Wagh","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib69","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/bioinformatics\/btx469","article-title":"ggseqlogo: a versatile R package for drawing sequence logos","volume":"33","author":"Wagih","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2018.12.017_bib70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib71","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.12.017_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.27389","article-title":"Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies","volume":"6","author":"Wang","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2018.12.017_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/imr.12507","article-title":"The HIV-1 envelope glycoprotein structure: nailing down a moving target","volume":"275","author":"Ward","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2018.12.017_bib74","doi-asserted-by":"crossref","first-page":"e1003738","DOI":"10.1371\/journal.ppat.1003738","article-title":"Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes","volume":"9","author":"Wibmer","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.12.017_bib75","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/JVI.80.2.835-844.2006","article-title":"Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant","volume":"80","author":"Wu","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.12.017_bib76","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.12.017_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.chom.2017.07.001","article-title":"Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin","volume":"22","author":"Wu","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"W1","key":"10.1016\/j.immuni.2018.12.017_bib78","doi-asserted-by":"crossref","first-page":"W213","DOI":"10.1093\/nar\/gkv404","article-title":"CATNAP: a tool to compile, analyze and tally neutralizing antibody panels","volume":"43","author":"Yoon","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2018.12.017_bib79","doi-asserted-by":"crossref","first-page":"vex003","DOI":"10.1093\/ve\/vex003","article-title":"In\u00a0vivo mutation rates and the landscape of fitness costs of HIV-1","volume":"3","author":"Zanini","year":"2017","journal-title":"Virus Evol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107476131830565X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107476131830565X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:04:45Z","timestamp":1761033885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107476131830565X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S107476131830565X"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2018.12.017","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/406355","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2018.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}